Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017
Management of refractory dyspnoea in COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021
Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
Exertional dyspnea relief following bronchodilation in COPD: Role of neural respiratory drive Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015
The impact of dyspnoea and strategies used by lung fibrosis patients to relieve breathlessness. Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Delayed adjustment in maintenance therapy in patients with worsening asthma symptoms Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002
Mechanisms, measurement and management of exertional dyspnoea in asthma Source: Eur Respir Rev, 26 (144) 170015; 10.1183/16000617.0015-2017 Year: 2017
Opioids for chronic refractory breathlessness: patient predictors of beneficial response Source: Eur Respir J 2013; 42: 758-766 Year: 2013
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015
Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease Source: ERJ Open Res, 6 (1) 00243-2019; 10.1183/23120541.00243-2019 Year: 2020
Impact of anemia on dyspnea on exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Exercise assessment in different diseases Year: 2011
Two-year safety of targeted lung denervation in patients with moderate to severe COPD Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Physical therapy in the treatment of chronic cough Source: Annual Congress 2012 - PG12 Cough: from basic mechanisms to clinical approaches Year: 2012
The effect of respiratory rehabilitation on dyspnea intensity and physical condition in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 66s Year: 2002
Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007
Distribution of dyspnea etiologies among patients with either acute or chronic breathlessness and normal cardiorespiratory function Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012